contraindications to semaglutide cagrilintide Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early Semaglutide (Ozempic) Side Effects &

95% CI 0.60, 0.79) users,59 and also in AD in a separate study for exenatide which used claims data from a 20% random sample of Medicare beneficiaries with T2DM.60 Two further studies using TriNetX electronic health records (EHRs) but without an active comparator group found a beneficial association between GLP-1RAs and dementia risk in people with T2DM and obesity.61 62 On this same dataset, SGLT-2i was found to be slightly superior to GLP-1RAs for dementia risk (HR 0.92

Semaglutide is not for people who are only looking to lose a small amount of weight for cosmetic reasons

100C | LiHV Step into the High Voltage World - The Most Affordable LiHv Solution

Why this matters: Compounded GLP-1 medications are not FDA-approved

Studies have shown that GLP-1 medications can lead to significant reductions in body weight, improve overall health profiles, and lower the risk of health issues related to blood pressure and cholesterol